Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NQO1 | CCLE | pan-cancer | AAC | 0.62 | 2e-28 |
mRNA | NQO1 | GDSC1000 | pan-cancer | AAC | 0.59 | 7e-50 |
mRNA | TNFRSF12A | GDSC1000 | pan-cancer | AAC | 0.38 | 5e-16 |
mRNA | FAM129B | GDSC1000 | pan-cancer | AAC | 0.36 | 8e-13 |
mRNA | MYOF | GDSC1000 | pan-cancer | AAC | 0.36 | 2e-16 |
mRNA | ABCC3 | GDSC1000 | pan-cancer | AAC | 0.35 | 8e-21 |
mRNA | YAP1 | GDSC1000 | pan-cancer | AAC | 0.34 | 2e-12 |
mRNA | AVPI1 | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-17 |
mRNA | KDELR3 | GDSC1000 | pan-cancer | AAC | 0.34 | 8e-15 |
mRNA | ERRFI1 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-11 |